Blueprint Medicines Corporation (BPMC) vs Cytokinetics, Incorporated (CYTK)
Detailed comparison between Blueprint Medicines Corporation, Cytokinetics, Incorporated.Total Return (%)
Blueprint Medicines Corporation (BPMC)Cytokinetics, Incorporated (CYTK)
Which stock do you think will perform better?
Blueprint Medicines Corporation
BPMC
Cytokinetics, Incorporated
CYTK
| Metric | Blueprint Medicines Corporation (BPMC) | Cytokinetics, Incorporated (CYTK) |
|---|---|---|
| Current Price | $129.46 | $37.23 |
| Change | 0.00 (0.00%) | -1.66 (-4.27%) |
| Market Cap | $8.37B | $4.45B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -137.72 | -6.91 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $129.65 | $61.38 |
| 52-Week Low | $73.04 | $29.31 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-2.51 | $-5.29 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| BPMC | 0.98% | 15.63% | 10.83% | 65.06% | 308.26% | 308.26% |
| CYTK | 14.80% | -18.75% | -35.16% | 48.09% | 456.50% | 456.50% |